文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

孟加拉国达卡化脓性汗腺炎的患病率:一项基于医院的研究。

Prevalence of Hidradenitis Suppurativa in Dhaka, Bangladesh: A Hospital-Based Study.

作者信息

Bhuiyan Mohammed Saiful Islam, Noor Towhida, Akhter Sania, Tahnin Nur-A-Tasmin, Bouazzi Dorra, Medianfar Cecilia E, Christensen Robin, Jemec Gregor B E

机构信息

Department of Dermatology and Venereology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh.

Department of Dermatology and Venereology, Metador Diagnostic and Wellness Center, Dhaka, Bangladesh.

出版信息

Dermatology. 2025 Jul 7:1-6. doi: 10.1159/000538444.


DOI:10.1159/000538444
PMID:40623401
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12233970/
Abstract

BACKGROUND: The prevalence of hidradenitis suppurativa (HS) varies widely in different epidemiologic studies from different parts of the world and very few data are available from South Asia. OBJECTIVES: The aim of this study was to determine the prevalence of HS in Dhaka, Bangladesh. METHODS: An exploratory, cross-sectional, and descriptive study was done among 2,500 consecutive healthy accompanying adults of patients attending at the outpatient department (except dermatology), at the Bangabandhu Sheikh Mujib Medical University Hospital, Dhaka, Bangladesh. This was an initiative of Global Hidradenitis Suppurativa Atlas (GHiSA), and it therefore followed the approach previously published by Bouazzi et al. Results: Out of a total of 2,377 accompanying persons, 3 were diagnosed with HS. The point prevalence was 0.13% (CI: 0.04%-0.37%), sensitivity was 0.1 (3/3), specificity was 0.1 (23/23), positive predictive value positive predictive value (PPV) was 0.1 (3/3), and the negative predictive value was 0.1 (23/23). The median age of the HS patients was 45.0, and the median BMI was 28.0. All 3 confirmed HS were male. CONCLUSIONS: The prevalence of HS in Bangladesh is lower than in western countries and other GHiSA studies like Singapore, Ghana, and Greenland.

摘要

背景:在来自世界不同地区的不同流行病学研究中,化脓性汗腺炎(HS)的患病率差异很大,而南亚地区的数据非常少。 目的:本研究旨在确定孟加拉国达卡HS的患病率。 方法:在孟加拉国达卡的班加班杜·谢赫·穆吉布医科大学医院门诊部(皮肤科除外)对2500名连续就诊患者的健康陪同成年人进行了一项探索性、横断面描述性研究。这是全球化脓性汗腺炎地图集(GHiSA)的一项举措,因此遵循了Bouazzi等人先前发表的方法。结果:在总共2377名陪同人员中,有3人被诊断为HS。点患病率为0.13%(CI:0.04%-0.37%),敏感性为0.1(3/3),特异性为0.1(23/23),阳性预测值(PPV)为0.1(3/3),阴性预测值为0.1(23/23)。HS患者的中位年龄为45.0,中位BMI为28.0。所有3例确诊的HS患者均为男性。 结论:孟加拉国HS的患病率低于西方国家以及其他GHiSA研究(如新加坡、加纳和格陵兰)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abbf/12233970/6c578429ca1c/drm-2025-0000-0000-538444_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abbf/12233970/6c578429ca1c/drm-2025-0000-0000-538444_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abbf/12233970/6c578429ca1c/drm-2025-0000-0000-538444_F01.jpg

相似文献

[1]
Prevalence of Hidradenitis Suppurativa in Dhaka, Bangladesh: A Hospital-Based Study.

Dermatology. 2025-7-7

[2]
Prevalence of Hidradenitis Suppurativa in Athens, Greece: A Cross-Sectional Study Based on a Validated Questionnaire.

Dermatology. 2025-7-7

[3]
Prevalence of Hidradenitis Suppurativa in the Netherlands: A Cross-Sectional Study as Part of the Global Hidradenitis Suppurativa Atlas (GHiSA).

Dermatology. 2025-7-7

[4]
Prevalence of Hidradenitis Suppurativa in Serbia: Validation of a Screening Questionnaire.

Dermatology. 2025-7-7

[5]
Prevalence of Hidradenitis Suppurativa in Lund and Gothenburg, Sweden: An Analysis from the Global Hidradenitis Suppurativa Atlas Initiative.

Dermatology. 2025-7-7

[6]
Prevalence of Hidradenitis Suppurativa in Poland.

Dermatology. 2025-7-7

[7]
Validation of the real-world application of the Hidradenitis Suppurativa Quality of Life (HiSQOL) score to adults with hidradenitis suppurativa.

Br J Dermatol. 2025-1-24

[8]
Hidradenitis Suppurativa Prevalence in Indonesia: A Cross-Sectional Multicenter Study and Validation of a Screening Questionnaire.

Dermatology. 2025-7-7

[9]
Prevalence of Hidradenitis Suppurativa in Xi'an, China: A Single Center Epidemiological Study.

Dermatology. 2024-12-20

[10]
Prevalence of Hidradenitis Suppurativa in Balangoda, Sri Lanka.

Dermatology. 2025-7-7

引用本文的文献

[1]
Prevalence of Hidradenitis Suppurativa: A Meta-Analysis of Global Hidradenitis Suppurativa Atlas Studies.

JAMA Dermatol. 2025-8-27

本文引用的文献

[1]
The Global Hidradenitis Suppurativa Atlas Methodology: Combining Global Proportions in a Pooled Analysis.

Dermatology. 2024

[2]
Hidradenitis Suppurativa Prevalence in Nuuk, Greenland: Physician Validation of a Hidradenitis Suppurativa Questionnaire in a Greenlandic Setting.

Acta Derm Venereol. 2023-1-10

[3]
Prevalence of Hidradenitis Suppurativa in Berekum, Ghana.

Br J Dermatol. 2022-10

[4]
Clinico-Epidemiological Characteristics of Hidradenitis Suppurativa: A Retrospective Cohort Study from a Tertiary Care Centre in Northern India.

Indian Dermatol Online J. 2021-6-20

[5]
Misdiagnoses and barriers to care in hidradenitis suppurativa: A patient survey.

Australas J Dermatol. 2021-11

[6]
Gender Differences in Service Quality of Upazila Health Complex in Bangladesh.

J Patient Exp. 2021-4-13

[7]
The epidemiology of hidradenitis suppurativa.

Br J Dermatol. 2020-12

[8]
Delayed Diagnosis of Hidradenitis Suppurativa and Its Effect on Patients and Healthcare System.

Dermatology. 2020

[9]
Comorbidities of hidradenitis suppurativa: A review of the literature.

Int J Womens Dermatol. 2019-7-2

[10]
Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project.

J Am Acad Dermatol. 2019-7-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索